SCINAI IMMUNOTHERAPEUTICS LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4435 USD | -3.13% |
|
-3.38% | -25.51% |
Chart calendar Scinai Immunotherapeutics Ltd.
28769c76.J7j_VORm0ZADautpKBVWQL_LswSd1XkOCX8Vha-Ozrc.b8yUNacXtP9cDL5ca145CvCz-kjJmkFmWghd1tvbjIcX88oHqjKi3UUDnA~ba1086dac2644b8018e4c2c7d34e9669
Upcoming events on Scinai Immunotherapeutics Ltd.
Past events on Scinai Immunotherapeutics Ltd.
| Today | Q4 2023 Earnings Release (Projected) |
| 17/04/2024 06:15 pm | Dermatology Drug Development Summit |
| 17/04/2024 02:30 pm | Dermatology Drug Development Summit |
| 18/03/2024 | BioEurope Spring Conference |
| 05/03/2024 | MIXiii International Life Science and Health-tech Conference |
| 09/01/2024 08:30 pm | Business Update Call |
| 06/11/2023 04:30 am | BIO-Europe Conference |
| 31/10/2023 05:53 pm | Q3 2023 Earnings Release |
| 24/10/2023 03:30 am | CPHI Barcelona Conference |
| 13/09/2023 | LSX World Congress |
| 11/09/2023 | H.C. Wainwright Global Investment Conference |
| 24/08/2023 06:30 pm | Annual General Meeting |
| 11/08/2023 06:30 pm | Q2 2023 Earnings Release |
| 16/05/2023 02:15 am | Q1 2023 Earnings Release |
| 18/04/2023 01:55 am | Q4 2022 Earnings Release |
| 21/03/2023 04:00 pm | BIO-Europe Spring Conference |
| 07/02/2023 02:45 am | BIO CEO and Investor Conference |
| 23/01/2023 | Transdermal and Microneedle Drug Delivery Conference |
| 09/01/2023 11:00 pm | Biotech Showcase |
| 09/01/2023 | JP Morgan Healthcare Conference |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -21,3 -15,2 -40.25% | -22,7 -19,1 -18.74% | 0,00 | -10,8 -12,3 11.81% | -11,1 -13,4 17.46% | -10,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -24,3 -13,2 -83.83% | -31,6 -19,1 -65.49% | 0,00 | -12,4 -15,9 21.83% | -5,80 -19,2 69.81% | 0,00 |
|
Net income Million USD | Released Forecast Spread | -24,3 -13,2 -83.83% | -31,6 -19,1 -65.49% | -1,36 | -12,4 -14,2 12.29% | -5,80 -15,7 63.13% | -7,08 |
|
EPS USD | Released Forecast Spread | -0,94 -0,50 -88.72% | -0,95 -0,60 -57.93% | -1,22 | -8,68 -4,20 -106.68% | -4,00 -5,62 28.83% | -1,78 |
| Announcement Date | 30/04/19 | 12/06/20 | 13/05/21 | 28/03/22 | 17/04/23 | - |
Quarterly results
| Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | |
|
EBIT Million USD | Released Forecast Spread | -3,40 -4,84 29.68% | -2,49 -3,36 25.73% | -3,30 -3,30 -0.02% | 1,12 -3,60 131.21% | -6,77 -3,13 -116.64% | -3,19 -2,60 -22.54% | -2,60 -2,80 7.32% | -2,10 -2,70 22.15% | -2,50 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,34 -6,90 51.55% | -2,83 -3,40 16.72% | -3,93 -3,70 -6.34% | 1,09 -4,00 127.21% | -0,57 -4,20 86.48% | -3,76 -2,70 -39.33% | 3,11 -3,00 203.57% | |||
|
Net income Million USD | Released Forecast Spread | -2,86 | -3,34 -4,97 32.76% | -2,83 -3,52 19.64% | -3,93 -3,70 -6.34% | 1,09 -4,00 127.21% | -0,57 -4,03 85.89% | -3,52 -2,61 -34.67% | -3,76 -2,85 -32% | 3,11 -3,09 200.55% | -2,91 |
|
EPS USD | Released Forecast Spread | -2,53 | -2,48 -0,85 -191.79% | -2,39 -1,00 -139.26% | -0,06 -0,10 38.8% | 0,03 -0,10 129.1% | 0,00 -1,08 - | -1,20 -0,73 -64.38% | -1,20 -0,91 -31.87% | 0,80 -0,94 185.11% | -0,62 |
| Announcement Date | 30/11/21 | 28/03/22 | 01/06/22 | 25/08/22 | 30/11/22 | 17/04/23 | 15/05/23 | 11/08/23 | 31/10/23 | - |
| 01/05/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 04:00 pm | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 04:00 pm | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 04:30 pm | ALKERMES PLC: Q1 2024 Earnings Release |
| 02/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Scinai Immunotherapeutics Ltd.
| Today | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 01:35 am | QIAGEN N.V.: Q1 2024 Earnings Release |
| 29/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 29/04/2024 | SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release |
| 29/04/2024 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release |
| 29/04/2024 | MORPHOSYS AG: Q1 2024 Earnings Release |
| 27/04/2024 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 27/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SCNI Stock
- Calendar Scinai Immunotherapeutics Ltd.
